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During the formation of the insect peripheral nervous system (PNS), the cell adhesion receptor fasciclin II has been shown
to play a prominent role in axonal fasciculation and synapse formation during motor neuron outgrowth. In the moth
Manduca, fasciclin II (MFas II) is expressed both as a transmembrane isoform (TM-MFas II) and a glycosyl
phosphatidylinositol-linked isoform (GPI-MFas II). By using RNA and antibody probes, we have shown that these two
isoforms are expressed in nonoverlapping patterns: TM-MFas II is expressed exclusively by neurons and becomes localized
to their most motile regions, while GPI-MFas II is expressed primarily by the glial cells that ensheath the peripheral nerves.
This cell-type specificity of expression allowed us to monitor the nature of neuronal–glial interactions during PNS
development. The outgrowth of TM-MFas II-positive axons in many regions preceded the arrival of GPI-MFas II-expressing
glial processes that enwrapped them. In a few key locations, however, GPI-MFas II-positive glial cells differentiated before
the arrival of the first axons and prefigured their subsequent trajectories. Prior inhibition of GPI-MFas II expression
disrupted the subsequent outgrowth of axons at these locations but not elsewhere in the PNS. Our results suggest that the
two isoforms of MFas II play distinct roles with respect to cellular motility and nerve formation. © 2001 Academic Press



















The formation of the nervous system involves a complex
interplay between neurons and glia that is crucial to the
differentiation and survival of both cell types. In the devel-
oping central nervous system (CNS) of vertebrates and
invertebrates, glial cells prefigure many of the pathways
taken by migrating neurons and growing axons (Jacobs and
Goodman, 1989a; Kla¨mbt et al., 1991; Rakic, 1971; Silver,
1984), and perturbation of these interactions results in
significant pathfinding errors (Granderath and Kla¨mbt,
1999; Hatten, 1999; Hidalgo and Booth, 2000; Mason and
Sretavan, 1997). Neuronal-specific proteins have also been
shown to induce changes in glial differentiation that are
critical to their normal function (Rio et al., 1997; Zheng et
l., 1996). In the vertebrate peripheral nervous system
PNS), the roles of neurons and glia are reversed with
espect to guidance: growing axons act as scaffolds for
1 To whom correspondence should be addressed. Fax: 503-494-
p4253. E-mail: copenhav@ohsu.edu.
24igrating Schwann cell precursors and maintain their sur-
ival (Bhattacharyya et al., 1994; Mirsky and Jessen, 1999),
lthough later the ensheathing Schwann cells promote
euronal survival, as well as the maturation of the perineur-
al sheath and stabilization of the neuromuscular junction
Davies, 1998; Jessen and Mirsky, 1999; Sanes and Licht-
an, 1999). Guidance interactions between neurons and
lial cells in the PNS of insects are more diverse. Motor
xons initially orient along identified sets of glial cells
hen leaving the CNS (Bastiani and Goodman, 1986;
la¨mbt and Goodman, 1991) but then may be guided by a
ariety of substrates, including both ectodermal and meso-
ermal cell types and components of the extracellular
atrix (Anderson and Tucker, 1989; Rajan and Denburg,
997; Younossi-Hartenstein and Hartenstein, 1993). While
he pathfinding of peripheral axons is typically thought to
e independent of glial activity, in some instances, glial
caffolds prefigure neuronal tracts before the first axons
rrive (Carr and Taghert, 1988; Gorczyca et al., 1994).
The mechanisms that govern these interactions areoorly understood but are thought to involve a combination
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25Fasciclin II Isoforms in the PNSof diffusible, matrix, and membrane-associated cues, in-
cluding a variety of cell-adhesion molecules (CAMs).
Among the CAMs identified in the insect nervous system,
fasciclin II has been particularly well characterized for its
role in mediating neuron–neuron interactions. Fasciclin II
was first identified in the grasshopper nervous system as a
neuronal glycoprotein capable of promoting intercellular
adhesion (Bastiani et al., 1987; Harrelson and Goodman,
1988; Snow et al., 1988). Subsequent analysis in Drosophila
demonstrated that fasciclin II helps mediate axonal fascicu-
lation and growth cone guidance in the embryonic CNS and
PNS (Grenningloh et al., 1991; Lin et al., 1994; Lin and
oodman, 1994). Fasciclin II is a member of the
mmunoglobulin-related superfamily of CAMs (IgSFs) with
tructural similarity to the vertebrate receptor NCAM and
he Aplysia receptor apCAM (Grenningloh et al., 1990;
Mayford et al., 1992). Like NCAM and apCAM, the extra-
ellular portion of fasciclin II contains five immunoglobu-
in domains and two fibronectin type III domains. The
CAM/apCAM/fasciclin II subfamily is also unique in that
ach of these CAMs can be expressed as alternative iso-
orms with divergent membrane attachments: whereas
ost IgSFs occur either as transmembrane proteins or as
embrane-associated proteins anchored via a glycosyl
hosphatidylinositol (GPI) linkage, fasciclin II, NCAM, and
pCAM are expressed in both forms as a result of alterna-
ive mRNA splicing (Grenningloh et al., 1991; Mayford et
al., 1992; Nguyen et al., 1986). Aside from its role in axon
outgrowth, fasciclin II has been shown to participate in the
control of synaptic stabilization and growth, activity-
dependent plasticity, and proneural gene expression (Davis
et al., 1997; Garcia-Alonso et al., 1995; Goodman et al.,
997). However, while considerable work has been per-
ormed on the functions of transmembrane isoforms of
asciclin II, the role of the GPI-linked isoform and the
elative contributions of the different isoforms to specific
evelopmental processes have remained unexplored.
We recently cloned fasciclin II from the moth, Manduca
exta, and demonstrated that it plays an essential role in
uiding the migration of neurons and glial cells within the
mbryonic enteric nervous system (ENS; Wright et al.,
999). Using probes that selectively recognize the trans-
embrane (TM) and GPI-linked isoforms of Manduca fas-
iclin II (MFas II), we showed that TM-MFas II was ex-
ressed exclusively by motile neurons, while GPI-MFas II
as primarily expressed by glial cells (Wright and Copen-
aver, 2000). In addition to these distinct expression pat-
erns, each isoform of MFas II appears to mediate specific
unctions. Inhibition of TM-MFas II expression in the ENS
emonstrated that it helps promote neuronal migration and
xon outgrowth. In contrast, removal of GPI-MFas II had no
irect effect on neuronal motility but disrupted intercellu-
ar adhesivity among cells expressing this isoform. We have
ow used a combination of riboprobes and antibodies to
nvestigate whether isoform-specific expression patterns of
Fas II occur in the embryonic CNS and PNS. Unexpect-
dly, we have found that the pattern of MFas II in the CNS
Copyright © 2001 by Academic Press. All rightwhich is similar to the patterns of fasciclin II reported for
ther insects) is entirely due to the expression of TM-MFas
I. In contrast, the expression of GPI-MFas II is largely
onfined to glial populations associated with the developing
eripheral nerves. By selective manipulation of GPI-MFas II
xpression in embryonic culture, we have investigated the
otential role of these peripheral glial cells with respect to
xonal guidance in the PNS. Our results indicate that, in
ome instances, GPI-MFas II expression by specific glial
ells is relevant to axonal pathfinding, but, in other in-
tances, it is not.
MATERIALS AND METHODS
Embryos were collected from a stable Manduca sexta colony as
reviously described (Copenhaver and Taghert, 1989a). When
aintained at 25°C, embryos complete development in approxi-
ately 100 h (1 h is equivalent to 1% of development). Sets of
nternal and external markers characterized in previous work were
sed to identify particular stages of development (Copenhaver and
aghert, 1989a; Dorn et al., 1987). For studies employing whole-
ount immunoanalysis and in situ hybridization histochemistry,
mbryos were restrained in Sylgard-coated chambers and opened
long a lateral anterior–posterior line, flattened, and pinned in
lace. This dissection permitted visualization of the developing
NS and the complete innervation of the lateral body wall mus-
ulature on one side (one intact hemisegment per segment).
For tissue fixation, we used a modified version of our original
rotocol (Horgan et al., 1994) to enhance signal sensitivity while
educing tissue degradation. PBS-Triton (1.8 mM NaH2PO4, 8.4
mM Na2HPO4, 175 mM NaCl, 0.8% Triton X-100) was diluted 1:1
with stock (37.6%) formaldehyde solution (Mallinckrodt) and ad-
justed to pH 9.5 with 1 N NaOH. The tissue was fixed for 15 min
followed by 33 5-min washes in PBS-Triton. Immunohistochemi-
cal staining was performed as previously described (Horgan et al.,
1994). A mouse polyclonal antibody recognizing both MFas II
isoforms and two guinea pig antisera raised against unique se-
quences within each isoform were characterized by immunoblot
analysis (Wright and Copenhaver, 2000) and used for whole-mount
immunohistochemistry. Because both isoform-specific antibodies
were generated in the same host species, we were unable to perform
simultaneous double labeling with these two antibodies. Instead,
we visualized the TM-MFas II-specific antibody with alkaline
phosphatase (to generate a purple reaction product) and the mouse
antibody against both isoforms with a horseradish peroxidase
reaction (generating a brown reaction product; Horgan et al., 1994).
Isoform-specific riboprobes complementary to the mRNA se-
quences encoding each MFas II isoform were characterized in
Northern blots and used for whole-mount in situ hybridization
histochemistry, as previously described (Wright and Copenhaver,
2000).
For culture experiments, embryos were prepared essentially as
described (Wright et al., 1998), but, because the stages investigated
in these studies were much younger than in our previous work
(25–45% of development), the following modifications were intro-
duced: embryos at 25–28% of development were dechorionated in
sterile medium using fine forceps, but the inner extraembryonic
membranes were kept intact. A small opening was then made in
these membranes, permitting the insertion of a glass electrode
attached to a Hamilton syringe with polyethylene tubing. Approxi-
s of reproduction in any form reserved.
FIG. 1. Developmental expression of MFas II isoforms in the embryonic CNS. Each panel shows a representative abdominal ganglion (anterior
is towards the top of the page). (A) In situ hybridization histochemistry using a TM-MFas II-specific riboprobe stained a large number of neuronal
somata in an abdominal ganglion at 60% of development (white arrowhead indicates a set of UM cells). (B) 60% ganglion reacted with a GPI-MFas
II-specific probe produced much weaker staining in CNS neurons but robust staining in glial cells surrounding each of the peripheral nerves
leaving the ganglion (black arrows; white arrowhead indicates similar UM cells as in A). (C) Immunohistochemical labeling with a GPI-MFas
II-specific antibody produced no detectable staining within the CNS at 60% of development (or any other time during embryogenesis) but did
stain the peripheral glial cells (arrows). (D—I) Immunohistochemical staining with a TM-MFas II-specific antibody labeled specific sets of cells
and processes in a stage-specific manner. (D) TM-MFas II expression at 22% in the aCC/pCC cell cluster (black arrowheads), in a putative set of
RP neurons (white arrows), and in a set of nonneural cells that prefigure the transverse nerve (black arrows). (E) TM-MFas II expression at 30%
is still apparent in a few somata (lower arrowhead indicates aCC/pCC cell cluster) but was increasingly localized to their growing axons (upper
arrowhead indicates fascicle containing the aCC axon from the next anterior ganglion exiting the dorsal nerve). Strong labeling was also seen in
longitudinal fascicles running through the ganglion and in specific commissural tracts (white arrows indicate axons of the putative RP neurons
shown in D). Black arrows indicate persistent staining in the non-neural cells forming the transverse nerve. (F) At 45%, persistent TM-MFas II
staining was seen in the longitudinal fascicles and axons exiting the dorsal nerve (black arrowhead), but all commissural staining had disappeared.
Staining was also visible in the bilateral branches of the spiracular neurons entering the transverse nerve (arrows). (G) At 60%, eight separate
TM-MFas II-positive longitudinal fascicles could be distinguished within each hemisegment; axons within the transverse nerve (arrows) and
dorsal nerve (arrowhead) also remained immunopositive. (H) By 80%, all TM-MFas II immunoreactivity had disappeared from the CNS except
for a bilateral fascicle coursing through the transverse nerve (arrows). (I) By 2 days posthatch, TM-MFas II expression had reappeared in a pair of
UM cells (white arrowhead). (J, K) Ganglia at 40 and 60% of development double-stained by in situ hybridization histochemistry for TM-MFas


















27Fasciclin II Isoforms in the PNSmately 10 ml of either control or experimental solutions were then
introduced into the vicinity of the developing nervous system.
Embryos were cultured overnight at 37°C prior to fixation and
immunohistochemical staining. Phosphatidylinositol-specific
phospholipase C (PI-PLC) was obtained from Boehringer and di-
luted in sterile medium.
Oligodeoxynucleotides (ODNs) were prepared as phos-
phorothioate-modified 20-mers (Synthegen, Houston, TX) derived
from the mRNA sequence for GPI-MFas II. Three distinct regions
within the proximal 39 untranslated region (UTR) of GPI-MFas II
RNA were selected based on their predicted lack of strong second-
ry structure (Fenster et al., 1994). Specific 20-mers were then selected
rom within these regions by using the following criteria: predicted
ybridization to only one site within the GPI-MFas II sequence, GC
ontent , 50%, Tm values . 55°C, lack of self-complementarity or
poly-base sequences, and absence of significant sequence identity
with other known genes (determined using the NCBI BLAST program;
Altschul et al., 1990). The following ODNs were constructed: GPI-
ODN-1, corresponding to nt 2187–2207; GPI-ODN-2, corresponding
to nt 2398–2418; and GPI-ODN-3, corresponding to nt 2490–2510.
Sense and scrambled sequence ODNs were used as controls, as
previously described (Copenhaver and Wright, 2000). The ODNs were
HPLC-purified, filtered on a G25 Sephadex column, and then resus-
FIG. 2. MFas II isoform expression in the embryonic brain at 60%
M-MFas II mRNA and GPI-MFas II mRNA, respectively. (C, D) I
ascicles in profile that run between the brain and the subesopha
ilaterally paired clusters of putative glial precursor cells. Scale 5pended in sterile defined saline at 2 mg/ml. Working dilutions (0.1
Copyright © 2001 by Academic Press. All rightmg/ml) were prepared with serum-free culture medium and delivered
o cultured embryos as described above. After overnight incubation at
7°C, the preparations were fixed and immunostained with a mono-
lonal antibody recognizing the extracellular domain shared by both
soforms of MFas II. Each experimental manipulation was repeated a
inimum of three times by using replicate sets of identically staged
mbryos. Analysis of axon outgrowth in cultured preparations was
erformed by using photomicrographic and camera lucida tech-
iques.
RESULTS
Isoform-Specific Expression of MFas II in the
Central Nervous System
Previous work by Goodman and colleagues (1997) showed
that fasciclin II is dynamically expressed by characteristic
subsets of fasciculating axons in the nervous systems of
both grasshopper and fly embryos (Bastiani et al., 1987;
Grenningloh et al., 1991; Harrelson and Goodman, 1988).
To investigate the relative contributions of different fasci-
clin II isoforms with respect to this expression pattern, we
evelopment. (A, B) In situ hybridization histochemical labeling for
nostaining for the same isoforms. Arrowheads in C show labeled
ganglion (located ventral to the brain). Arrows in D indicate two
M.of d
mmuapplied isoform-specific probes against TM-MFas II and
s of reproduction in any form reserved.
28 Wright and CopenhaverGPI-MFas II to the developing CNS of Manduca throughout
embryogenesis. When embryos at ;60% of development
were reacted with a digoxigenin-labeled RNA probe against
TM-MFas II, a large number of cells within each segmental
ganglion showed strong labeling (Fig. 1A), including a set of
unpaired median (UM) cells near the posterior ventral
midline (white arrowhead). In contrast, an RNA probe
against GPI-MFas II produced only faint levels of staining
within the CNS (Fig. 1B), although a few cells consistently
stained more strongly, including a similar set of UM cells as
indicated in Fig. 1A (white arrowhead). Robust levels of
GPI-MFas II mRNA expression were also detected within
populations of glial cells distributed along the peripheral
nerves of each ganglion, demarcating the course of each
nerve from its origin at the margin of the ganglion (Fig. 1B,
arrows).
To determine the distribution of MFas II-related proteins
in the developing nervous system, we immunostained
staged embryos with either an antibody against the shared
extracellular domain of MFas II (recognizing both isoforms)
or antibodies against peptide sequences unique to each
MFas II isoform. Although some minor differences were
seen between the pattern of MFas II expression in Manduca
and fasciclin II staining reported in fly and grasshopper
(Grenningloh et al., 1991; Harrelson and Goodman, 1988),
the overall pattern of developmental expression was largely
conserved, involving characteristic sets of identified neu-
rons and their processes at specific stages of development.
Surprisingly, this entire pattern was recapitulated by TM-
MFas II immunostaining, whereas no detectable GPI-MFas
II expression was detected within the thoracic or abdominal
ganglia (Fig. 1C). At 22% of development (shortly after the
onset of neurogenesis), TM-MFas II expression could be
detected within the aCC/pCC cell clusters (Fig. 1D, arrow-
heads) and on the aCC axons projecting posteriorly in each
segment; these axons subsequently help pioneer the dorsal
nerve (equivalent to the intersegmental nerve in other
insects) of the next posterior ganglion (upper arrowhead in
Fig. 1E; arrowheads in Figs. 1F and 1G). Early TM-MFas II
expression was also seen more anteriorly on a bilateral pair
of neurons (white arrows) that by their position and projec-
tions may correspond to a set of RP neurons (Jacobs and
Goodman, 1989b; Sink and Whitington, 1991), and on cells
prefiguring the future transverse nerve at the anterior
boundary of each ganglion (equivalent to the segment
boundary nerve in Drosophila; black arrow in Fig. 1D). This
latter set of cells are nonneural cells that will later contrib-
ute to the “strap” structure that forms before the arrival of
axons in the transverse nerve (Carr and Taghert, 1988).
Throughout the remainder of embryogenesis, the pattern
of TM-MFas II expression was progressively modified as the
ganglia differentiated. At 30% of development, the most
robust staining was associated with a subset of longitudinal
axon fascicles extending between ganglia and within a
smaller number of commissural axons (Fig. 1E). Unlike
other insects, the strongest commissural staining in
Manduca was seen in the processes of a bilateral pair of
Copyright © 2001 by Academic Press. All rightneurons (the putative RP cells identified in Fig. 1D; white
arrows) which extended contralateral processes across the
posterior boundary of the anterior commissure. Fainter
staining was also seen in another set of axons at the anterior
edge of this commissure, while no stained processes were
apparent in the posterior commissure. Persistent staining
was also seen in the “strap” cells just anterior to each
ganglion (Fig. 1E, black arrows). By 45%, TM-MFas II
expression was no longer detectable in either these nonneu-
ral cells or any of the commissures, although the outgrow-
ing axons of the spiracular motor neurons (originating from
the next anterior ganglion; Carr and Taghert, 1988) had
reached the developing transverse nerve and were now
TM-MFas II-positive (Fig. 1F, arrows). Of note was that
TM-MFas II staining appeared in these axons only after they
had traversed the median nerve (running longitudinally
between the two connectives) and had bifurcated out both
sides of the developing transverse nerve.
TM-MFas II expression in the CNS at 60% of develop-
ment was at its maximal level (Fig. 1G), including strong
staining of eight separate fascicles in each hemisegment
and in fascicles within the dorsal nerve (arrowhead) and
transverse nerve (arrows). By 80%, most of this immunore-
activity in the CNS had declined (Fig. 1H, arrows), but the
elimination of TM-MFas II from axons exiting the ganglia
occurred in a proximal–distal gradient so that expression
persisted within their more peripheral branches (described
below). Except for the earliest stages of neurogenesis (Figs.
1D and 1E), TM-MFas II immunoreactivity was excluded
from the somata of positively expressing cells and was
confined to their growing axons. This localized pattern of
expression was particularly evident in preparations double-
labeled for TM-MFas II expression by both in situ hybrid-
ization and immunohistochemistry (Figs. 1J and 1K), in
which the somata expressing TM-MFas II mRNA (shown in
purple) were often spatially separated from their immuno-
labeled processes (shown in brown). TM-MFas II immuno-
reactivity was no longer apparent in either the CNS or PNS
by the completion of embryonic development. Within 48 h,
however, a new phase of TM-MFas II expression had com-
menced in a set of UM cell somata (Fig. 1I, white arrow-
head), neuromodulatory neurons that continue to express
TM-MFas II in their somata and terminal processes
throughout postembryonic development (Knittel et al.,
2001).
Similar aspects of MFas II expression were seen in the
developing brain. A large number of neurons exhibited
strong levels of TM-MFas II-specific mRNA (Fig. 2A), while
only a few cells expressed much lower levels of GPI-MFas II
mRNA (Fig. 2B). As in the ventral ganglia, TM-MFas II
protein was primarily localized to specific axonal tracts
within the brain (Fig. 2C) and to a set of bilateral fascicles
connecting the brain and subesophageal ganglion (arrow-
heads). Unlike the ganglia, GPI-MFas II protein was also
present within a subset of cells in the brain (Fig. 2D,
arrows). Each lobe contained two populations of four to
eight clustered cells that appeared to be glial precursors,
s of reproduction in any form reserved.
G
n in A–
29Fasciclin II Isoforms in the PNSbased on their size and position (P.F.C., unpublished data).
GPI-MFas II immunoreactivity was first detectable in these
cells at 40% of development and persisted until about 90%,
by which time glial differentiation in the embryonic brain
FIG. 3. MFas II isoform expression in the peripheral nervous sys
strong labeling of the ensheathing glial cells surrounding all periph
(B) TM-MFas II immunostaining of an identically staged ganglion
fascicles within the dorsal nerve and transverse nerve (arrows i
magnification of a peripheral region of the dorsal nerve stained wit
strongly immunopositive. (D) Similar region of the dorsal nerve sh
is clearly visible under Nomarski optics (compare position of white
PI-MFas II mRNA stains the peripheral glia of the dorsal nerve (arr
o staining associated with the peripheral nerves. Scale 5 25 mMappears largely complete.
Copyright © 2001 by Academic Press. All rightMFas II Expression in the Peripheral Nervous
System
The distinction between TM-MFas II and GPI-MFas II
at 65% of development. (A) GPI-MFas II immunostaining shows
nerve branches up to their exit point from an abdominal ganglion.
s strong labeling in the CNS (see Fig. 1) and in a subset of axon
and B indicate similar regions of the dorsal nerve). (C) Higher
I-MFas II; glial cells ensheathing all peripheral nerve branches are
in C, immunostained for TM-MFas II. The unstained glial sheath
ws in C and D). (E) In situ hybridization histochemical labeling for
ad). (F) In situ hybridization labeling for TM-MFas II mRNA shows







owheexpression in the developing peripheral nervous system was




30 Wright and Copenhaverparticularly striking. GPI-MFas II immunoreactivity was
absent from the central ganglia (as noted above) but promi-
nent within the glial cells that surrounded the peripheral
FIG. 4. GPI-MFas II-positive glial cells prefigure the trajectory of
peripheral glial cells have coalesced to form a glial “bridge” (blac
(asterisk). (B) The first growth cones pioneering the anterior branch
defasciculate from the dorsal nerve. (C) By 60%, the glial bridge has
that serves as a scaffold for several peripheral nerves. (D) The DNa
(E, F) By 75%, GPI-MFas II-positive glial cells have ensheathed all
axon fascicles that have grown anteriorly (the DNa branch) and tho
indicate the position of the DNa branch. Scale 5 20 mM.nerves exiting the CNS (Fig. 3A; arrow indicates origin of 3
Copyright © 2001 by Academic Press. All righthe dorsal nerve). In contrast, TM-MFas II immunostaining
as localized to specific axon fascicles within the dorsal
nd transverse nerves and their peripheral branches (Fig.
ranch of the dorsal nerve. (A) At 40% of development, a cluster of
owhead) anterior to the dorsal nerve and proximal to the spiracle
he dorsal nerve (DNa branch; white arrowhead) have just begun to
ed its four-armed “star”-like morphology (Carr and Taghert, 1988)
ns have reached the bridge and have grown along its anterior arm.
e branches of the dorsal nerve, including the TM-MFas II-positive
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31Fasciclin II Isoforms in the PNSseen lining the entire surface of the dorsal nerve (Fig. 3C),
while TM-MFas II expression was confined to fasciculated
axons within the nerve (Fig. 3D). The unlabeled glial cells
surrounding the TM-MFas II-positive axons were easily
visible in Fig. 3D by using Nomarski optics (white arrow).
In situ hybridization labeling verified that these peripheral
glial cells expressed substantial levels of mRNA specific for
GPI-MFas II (Fig. 3E). No detectable levels of TM-MFas II
mRNA were detected in the dorsal nerve (Fig. 3F), confirm-
ing that all of the axonal TM-MFas II protein in this nerve
originated from centrally located somata. These results
show that, unlike the CNS, the pattern of MFas II mRNA
isoform expression and protein synthesis in the PNS pre-
cisely coincide.
Since the expression of MFas II isoforms was clearly
cell-type specific, we used our antibodies against TM-MFas
II and GPI-MFas II to examine neuronal–glial dynamics
within the developing PNS. These studies revealed two
distinct modes of interaction that contributed to the differ-
entiation of peripheral nerves. The first of these modes was
best illustrated during the formation of an anterior branch
of the dorsal nerve (DNa) commencing at about 40% of
development (Fig. 4). A subset of TM-MFas II-positive
growth cones (Fig. 4B, white arrowhead) was seen to leave
the dorsal nerve and grow anteriorly to contact a cluster of
nonneuronal cells that had already begun to express GPI-
MFas II (Fig. 4A, black arrowhead). These cells subse-
quently differentiated into a glial “bridge” (Fig. 4C) that
prefigured the routes taken by several peripheral nerve
branches, as previously shown by Carr and Taghert (1988).
Axons forming the DNa nerve branch had grown through
the bridge by 60% of development (Fig. 4D) and had begun
to extend towards muscles anterior to the spiracle (aster-
isk). By 75%, the DNa axons had reached their targets and
the bridge cells had differentiated into an enveloping glial
sheath (Figs. 4E and 4F). Thus, during the establishment of
the DNa nerve branch, glial cells expressing GPI-MFas II
formed a presumptive scaffold prior to the arrival of TM-
MFas II-positive axons.
In contrast, a second mode of interaction between growing
axons and peripheral glia was seen during the formation of the
lateral branch of the dorsal nerve (DNl; Fig. 4F), which
extended posterior to the spiracle to innervate dorsal muscu-
lature (Fig. 5). By 40% of development, TM-MFas II-positive
growth cones pioneering the DNl had grown beyond the
spiracle into the differentiating body wall mesoderm (Fig. 5B).
Unlike the formation of the DNa branch, there was no
evidence of glial cells prefiguring this pathway, either by
GPI-MFas II immunolabeling or when viewed with Nomarski
optics. Instead, faintly labeled glial precursors (GPI-MFas
II-positive) were seen advancing along the more proximal
portion of the DNl that had already formed (Fig. 5A). The
somatic mesoderm had begun to differentiate into organized
muscle fibers by 60% of development, and TM-MFas II-
positive terminal branches of the DNl had begun to extend
along these fibers (Fig. 5D). Glial cells had also grown along
the DNl into the vicinity of the developing muscles but had r
Copyright © 2001 by Academic Press. All rightot yet extended to the tips of the leading neuronal processes
Fig. 5C). However, by 75% of development (when initial
nnervation of the skeletal muscle was largely complete), glial
rocesses had not only elaborated over all of the TM-MFas
I-positive processes (thereby delineating the neuromuscular
unctions), but, in several locations, had extended well beyond
hem, ramifying over additional regions of the peripheral
uscle (compare Fig. 5E with 5F). Consequently, the resulting
etwork of GPI-MFas II-positive glial extensions was consid-
rably more elaborate at this stage than the TM-MFas II-
ositive motor neuron terminals (compare Fig. 5E with 5F).
To examine the interactions between the growing
xons and glial processes in better detail, we double-
abeled preparations with the anti-TM-MFas II antibody
using an alkaline phosphatase-conjugated secondary) fol-
owed by the anti-MFas II polyclonal antibody recogniz-
ng both isoforms (using an HRP-based detection system;
ee Materials and Methods). This strategy resulted in a
ompact purple labeling of the TM-MFas II-positive axon
ascicles that could readily be distinguished from the
ore diffuse brown labeling of the GPI-MFas II-positive
lial processes (Fig. 6). Unexpectedly, these preparations
evealed that the neuronal and glial processes contribut-
ng to a developing nerve overlapped only partially during
heir initial outgrowth. At 60% of development, the more
roximal segments of the dorsal nerve were entirely
nsheathed by the surrounding glial cells (Fig. 6A; proxi-
al is to the left). In the vicinity of the target muscles,
owever, the glial trajectories became largely indepen-
ent of the neuronal trajectories. Although, at this stage,
here were still numerous neuronal branches extending
eyond the glial cells, the leading glial processes were
ften found to be growing parallel to but separate from
heir neighboring axons. In Fig. 6A (which is a montage of
our focal planes), the black arrows indicate regions
here the axons and glial processes appeared to be in
irect contact, while the white and black arrowheads
ndicate regions where the axons and glial cells were
aximally separated in the z-axis. All TM-MFas II-
ositive processes subsequently became ensheathed by
PI-MFas II-positive glial cells (at 75%; Fig. 6B, solid
rrow). However, as indicated in Fig. 5, adjacent glial
ranches that were independent of TM-MFas II-
xpressing axons were also found on the target muscles
Fig. 6B, open arrow), apparently enwrapping an addi-
ional set of unlabeled neuronal processes.
Thus, unlike the formation of the DNa branch, in which
glial scaffold prefigured the trajectory of growing axons,
he formation of the DNl involved the initial extension of
M-MFas II-positive axons into the periphery prior to the
ifferentiation of any glial support. The subsequent out-
rowth of glial cells that eventually ensheathed the DNl
xons also proceeded in a manner that was partially inde-
endent of glial–neuronal contact. Whether the more elabo-
ate glial arbor seen in mature muscles (Figs. 5E and 6B)
eflects the selective down-regulation of TM-MFas II by a
s of reproduction in any form reserved.
32 Wright and CopenhaverFIG. 5. TM-MFas II-positive growth cones pioneer the lateral branch of the dorsal nerve prior to the arrival of GPI-MFas II-positive glia.
(A) At 40% of development, GPI-MFas II immunoreactivity is only faintly detectable in the most distal cluster of glial cells on the DNl
branch (the spiracle is just out of the field of view to the left). (B) TM-MFas II-positive processes pioneering the DNl branch have already
extended significantly beyond the most distal glial cells that can be detected by immunolabeling or Nomarski optics (compare with Fig.
3D). (C, D) By 60%, GPI-MFas II-positive glial cells have spread laterally along the DNl branch but still have not encompassed the most
distal terminals of the TM-MFas II-positive axons that have extended onto the differentiating skeletal muscle. (E, F) By 75%, GPI-MFas
II-positive glial processes now extend over the entire DNl and significantly beyond the most distal TM-MFas II-positive nerve terminals.
Scale 5 20 mM.

































































33Fasciclin II Isoforms in the PNSsubset of motor axons or is due to glial ensheathment of
other MFas II-negative cell types is discussed below.
Guidance of TM-MFas II-Positive Axons
by GPI-MFas II-Positive Glia
Our observations that growing axons expressing TM-
MFas II colocalize with GPI-MFas II-positive glial cells in a
variety of circumstances suggested that neuronal–glial in-
teractions might play a role in axonal pathfinding. In
particular, the formation of the GPI-MFas II-positive glial
bridge prior to the outgrowth of the TM-MFas II-positive
DNa axons (Fig. 4) raised the possibility that these glia form
a requisite scaffold that guides these axons towards their
correct targets, and that this neuronal–glial interaction
might be fasciclin II-dependent. We therefore treated cul-
tured embryos with low doses of PI-PLC at 35% of devel-
opment (shortly before DNa outgrowth) and allowed them
to develop overnight at 37°C. In previous studies, we
showed that PI-PLC treatment (which selectively cleaves
GPI linkages) was an effective means of removing GPI-
MFas II, but not TM-MFas II, from cell membranes both in
itro and in vivo (Wright et al., 1999; Wright and Copen-
aver, 2000). In cultured control embryos, the GPI-MFas
I-positive bridge glia formed normally (not shown), and the
ranches of both the DNa and DNl nerves grew along their
ppropriate trajectories (Fig. 7A; white and black arrow-
eads, respectively). The extension of the DNl into the
eriphery was similarly unperturbed in PI-PLC-treated em-
ryos (Figs. 7B–7D, black arrows): both the overall length of
he DNl (averaging ;200 mm) and its innervation of target
muscles in enzymatically treated embryos were indistin-
guishable from controls (not shown).
In contrast, the trajectory of the DNa branch was mark-
edly perturbed in 92% of treated embryos, which exhibited
a variety of abnormal phenotypes (Figs. 7B–7D, white ar-
rowheads). One-third of treated embryos exhibited a com-
plete failure in the defasciculation of the DNa from the DNl
(Fig. 7C). The divergence of the DNa from the DNl pro-
ceeded normally in the remaining animals (compare Fig. 7A
with 7B and 7D), indicating that GPI-MFas II-positive
bridge cells were not essential for the initial guidance of the
DNa growth cones away from the DNl. The subsequent
trajectories taken by these processes was often abnormal,
however. In 16% of these embryos, the DNa axons stalled
approximately at the position of the bridge and extended
abnormal branches in several inappropriate directions (Fig.
7B). More frequently, the DNa branches emerged at variable
locations along the DNl and exhibited a “switchback”
phenotype (Fig. 7D), indicating the presence of additional
guidance cues capable of misdirecting the DNa growth
cones when GPI-coupled guidance cues associated with the
bridge were disrupted.
To determine whether the formation of the bridge itself
was disrupted in these preparations, we also immuno-
stained embryos with a variety of antisera that label glial
cells in other insect species; unfortunately, none of these t
Copyright © 2001 by Academic Press. All righteagents provided a convincing independent marker for
anduca embryonic glia. Moreover, while PI-PLC treat-
ents selectively affected the outgrowth of the DNa but
ot the DNl branch, these results might be due in part to
he removal of additional GPI-linked molecules besides
PI-MFas II. We therefore designed a panel of antisense
hosphorothioate ODNs against unique sequences within
he 39 UTR of GPI-MFas II as a means of selectively
nhibiting the expression of this isoform. Several published
tudies have previously demonstrated that antisense ODNs
irected against the 39 UTR regions of specific mRNAs can
ave potent inhibitory effects on protein expression
Chiang et al., 1991; Lipp et al., 1995; Ronnov-Jessen and
etersen, 1996), and we have successfully used this strategy
o inhibit TM-MFas II expression in migratory neurons
Wright and Copenhaver, 2000). Each ODN was applied to
ultured embryos at 28–30% of development, after the
nitial formation of the dorsal nerve (Fig. 1E) but prior to the
ifferentiation of the glial bridge and outgrowth of the DNa
ranch (see Figs. 4A and 4B). After application of the ODNs,
he preparations were allowed to develop for an additional
2–16 h, then fixed and immunostained with an antibody
hat recognized the conserved extracellular domain of the
wo MFas II isoforms. This protocol allowed us to monitor
oth the trajectories of TM-MFas II-positive axons and
esidual levels of GPI-MFas II expression in the adjacent
lial cells in these culture preparations.
Of the three GPI-MFas II-specific ODNs employed, two
f them (GPI-1 and GPI-3) produced no significant changes
n dorsal nerve formation: both the levels of GPI-MFas II
xpression by the bridge glia and the trajectory of the DNa
erve branch in embryos treated with these ODNs were
ndistinguishable from cultured control preparations (Figs.
A and 9A). In contrast, exposure to ODN GPI-2 frequently
esulted in aberrant glial bridge formation and disrupted
Na outgrowth (Figs. 8 and 9). Although somewhat vari-
ble, the level of GPI-MFas II expression by the glial cells in
hese embryos was often reduced when compared with
ontrol cultures, and the overall organization of the bridge
as noticeably disrupted (Figs. 8B–8F). In contrast, the level
f TM-MFas II expression in the outgrowing axons of the
orsal nerve appeared unchanged, demonstrating that the
ffect of ODN GPI-2 on fasciclin II expression was isoform-
pecific. Concurrent with these effects on bridge formation,
DN GPI-2 also induced a range of defects in the formation
f the DNa branch that were similar to the abnormalities
een in PI-PLC-treated embryos. In some preparations, the
Na was completely absent (Figs. 8B and 9B). More fre-
uently, axons could be seen to have left the dorsal nerve at
pproximately the normal position of the DNa but then
talled or branched inappropriately around the disorganized
ridge glia (Figs. 8C, 8D, 9C, and 9D). In a small number of
egments, the DNa exhibited a “switchback” phenotype
Figs. 8E and 9E) similar to that shown in Fig. 7D, in which
xons that would normally extend through the bridge to
ore lateral muscle targets instead projected back towardshe CNS. Preparations treated with sense and scrambled













34 Wright and Copenhaversequence control ODNs (containing the same combination
of nucleotide residues as ODN-GPI-2) were indistinguish-
FIG. 6. TM-MFas II-positive axons and GPI-MFas II-positive glial
processes follow partially independent trajectories. (A) Peripheral
region of the DNl in a preparation immunostained to show TM-MFas
II-positive axons (purple) and GPI-MFas II-positive glial processes
(brown; this figure is a montage of four focal planes). Although the
neuronal processes extend substantially beyond the glial cells at this
stage, the trailing glial cells remain closely apposed to the axons at
only some positions (arrows). Elsewhere, the glial processes follow
distinct trajectories (white and black arrowheads indicate a region
where neuronal and glial processes are completely separate in the
z-axis). (B) By 75% of development, all of the TM-MFas II-positive
axons are completely ensheathed by GPI-MFas II-positive glial cells
(black arrow). However, additional glial branches (GPI-MFas II-
positive) extend onto adjacent regions of the target muscles devoid of
any TM-MFas II-positive axons (open arrow). Scale 5 20 mM.able from other control preparations (not shown).
Copyright © 2001 by Academic Press. All rightThese results substantiate our data obtained using PI-
LC treatments, demonstrating a functional role for
euronal–glial interactions in the formation of the DNa
erve. Whether GPI-MFas II serves as a bona fide axonal
uidance cue or is simply needed for the differentiation of
he glial bridge (which subsequently provides other guid-
nce cues required for DNa outgrowth) remains to be
etermined. Nevertheless, our results indicate that the
ormation of some nerve pathways in the PNS requires
xonal guidance by preformed glial assemblies, while, in
ther instances, the outgrowth of neuronal and glial pro-
esses appears to proceed in a partially independent man-
er.
DISCUSSION
Isoform-Specific Expression Patterns of MFas II
during Neural Development
The data presented in this paper demonstrate compelling
differences between the distribution of MFas II isoforms in
the developing nervous system, both in terms of cell type-
specific expression and subcellular localization. TM-MFas
II was expressed exclusively by neurons and was localized
to regions of active motility (elongating axons and growth
cones). In contrast, GPI-MFas II protein was found almost
exclusively on peripheral glial cells and was distributed
uniformly across their surface membranes. The overall
pattern of TM-MFas II in the embryonic CNS recapitulated
the patterns of fasciclin II described in other insects (Gren-
ningloh et al., 1991; Harrelson and Goodman, 1988), al-
though there were some notable differences with respect to
the initial sequence of fasciclin II expression by identified
neurons and specific axon fascicles. However, this is the
first demonstration that all neuronal fasciclin II expression
in the CNS consists of the transmembrane isoform. We also
found that TM-MFas II protein was rapidly localized to the
growing regions of developing neurons, so that their somata
were only briefly immunopositive at the time of initial
outgrowth (Figs. 1D and 1E). The progressive redistribution
of TM-MFas II protein from the neuronal somata into their
distal processes was particularly evident in preparations
that were double-labeled to show TM-MFas II mRNA and
protein expression (Figs. 1J and 1K). These observations are
consistent with the localized distributions of fasciclin II
reported in grasshopper and fly (Bastiani et al., 1987; Gren-
ningloh et al., 1991; Harrelson and Goodman, 1988).
The striking lack of GPI-MFas II protein in neurons
within the CNS was unexpected, both because of the
extensive analyses of fasciclin II in other systems and
because of the presence of low but detectable levels of
GPI-MFas II-specific mRNA in the ventral ganglia (Fig. 1B)
and brain (Fig. 2B). The expression of mRNA encoding both
isoforms in CNS neurons might reflect “leaky” transcrip-
tional regulation of the two splice variants, although no
evidence for this phenomenon was seen within the GPI-
MFas II-positive glial cells in the peripheral nerves (Fig. 3).

















35Fasciclin II Isoforms in the PNSPrevious work on the ENS also showed no evidence of
mRNA expression for a particular isoform in the absence of
detectable protein (Wright and Copenhaver, 2000). It is
possible that low levels of GPI-MFas II protein in the CNS
were not detectable by immunohistochemical staining, but
the sensitivity of the antibodies used in this study argues
against this possibility. Whether mRNA encoding GPI-
MFas II is simply never translated in CNS neurons or
whether there is a rapid degradation of GPI-MFas II in these
cells is unknown, although we have shown that both MFas
II isoforms can be rapidly down-regulated in other contexts
(Wright and Copenhaver, 2000). In general, however, our
data show that developing neurons express only the trans-
membrane isoform of fasciclin II, while the GPI-linked
isoform is primarily confined to peripheral glia.
The consistent expression of GPI-MFas II the peripheral
FIG. 7. Enzymatic removal of GPI-MFas II from the bridge glial c
All preparations were immunostained for TM-MFas II. (A) Con
outgrowth of both the DNa (white arrowhead) and the DNl branc
treated with PI-PLC prior to the outgrowth of the DNa, a variety o
a preparation in which the DNa defasciculated from the dorsal nerv
stalled and sent short processes in several inappropriate directi
defasciculate from the dorsal nerve. (D) Preparation in which the D
phenotype, curving proximally back towards the CNS. In all of thes
arrowheads). Scale 5 20 mM.glial cells provided an unambiguous means of visualizing s
Copyright © 2001 by Academic Press. All righthe distribution of these cells throughout most of embryo-
enesis (Figs. 3, 4, and 6). Although the lack of additional
ntibodies that unambiguously labeled Manduca glial cells
imited some aspects of our analysis, we were nevertheless
ble to monitor the interactions between growing axons
nd their glial partners in specific locations. Still unre-
olved is the source of these peripheral glial populations. In
rosophila, an identified population of exit glia originates
rom stem cells in the CNS and delineates the positions at
hich the peripheral nerves leave the CNS (Jacobs and
oodman, 1989b). Subsequent work has indicated that the
rogeny of these cells continue to migrate along the grow-
ng axons in a manner reminiscent of Schwann cell migra-
ion in the vertebrate CNS (Edwards et al., 1993; Sepp et al.,
000). In other regions, a mesodermal origin has been
ndicated for at least some of the peripheral glia that form
isrupts the formation of the DNa branch but not the DNl branch.
embryo maintained in normal culture medium showed normal
ck arrowhead; asterisk indicates the spiracle). (B—D) In embryos
ormalities were subsequently detected in the DNa. (B) Example of
rectly and grew into the normal vicinity of the glial bridge but then
(C) Preparation in which the DNa branch completely failed to
ranch defasciculated correctly but then exhibited a “switchback”







e precaffolds for nerve growth in Drosophila (Gorczyca et al.,
s of reproduction in any form reserved.
36 Wright and CopenhaverFIG. 8. Inhibition of GPI-MFas II expression with an antisense ODN reduces GPI-MFas II expression in peripheral glia and disrupts the
formation of both the glial bridge and the DNa nerve. All preparations were immunostained with an antibody against the shared
extracellular domain of MFas II. (A) Control embryo grown in normal culture medium exhibited normal bridge formation and DNa
outgrowth from the dorsal nerve (DN). The peripheral glia lining the branches of the dorsal nerve and forming the glial bridge showed robust
levels of GPI-MFas II expression. (B–F) Embryos treated with ODN GPI-2 showed a variety of defects in bridge formation and DNa
outgrowth. (B) Example of a peparation in which the DNa failed to fasciculate from the dorsal nerve; the glia surrounding the branches of
the dorsal nerve also showed substantially reduced levels of GPI-MFas II expression, and the glial cells that normally form the bridge had
not coalesced correctly. (C, D) Two examples of preparations in which the DNa axons emerged from the dorsal nerve at approximately the
normal position but then stalled and send short processes in several inappropriate directions. The glial bridge cells showed reduced levels
of GPI-MFas II expression and appeared disorganized. (E) Preparation in which the DNa branch exhibited a “switchback” phenotype after
reaching the disorganized glial bridge. (F) Preparation in which the bridge glia expressed more robust levels of GPI-MFas II than seen in B–E,
but the bridge still appeared malformed and the DNa axons grew in several inappropriate directions. DNl indicates the lateral branch of the
dorsal nerve, which was unaffected. Asterisks indicate the position of the spiracle. Scale 5 20 mM.











other nerves that extend through the bridge are not shown. (B–E)
37Fasciclin II Isoforms in the PNS
Copyright © 2001 by Academic Press. All right1994), and several identified glial structures in Manduca
(including the glial bridge that guides the DNa nerve) also
appear to arise within surrounding mesodermal tissues
prior to the arrival of any peripheral growth cones (Fig. 4;
Carr and Taghert, 1988). Glial phenotypes have been shown
to be induced in mesodermal cells by glial-specific tran-
scription factors (Bernardoni et al., 1998), suggesting that a
combination of ectodermal and mesodermal precursors
may contribute to peripheral glial populations in insects. A
complete analysis of the different glial populations de-
scribed in this study will require additional markers that
can be used to trace their origins in better detail.
Unlike Drosophila, in which motor terminals have been
reported to remain incompletely ensheathed (Sepp et al.,
2000), all of the efferent branches and motor terminals in
Manduca appeared to become wrapped by glial processes
during embryogenesis, a relationship that is maintained
throughout postembryonic development (Knittel et al.,
2001). In this regard, the neuromuscular junction of
Manduca is more similar to that of vertebrates than has
been described in flies (Atwood et al., 1993; Rheuben, 1992).
However, the behavior of the outgrowing glial cells was
notable in that they clearly followed additional guidance
cues besides the TM-MFas II-positive motor axons: the
leading glial processes were often seen extending in parallel
but independent of the motor axons (Fig. 6), only subse-
quently making contact with the adjacent axons and en-
wrapping them. Moreover, we also found that some GPI-
MFas II-positive glial processes grew substantially beyond
the TM-MFas II-positive motor terminals on mature
muscles (Figs. 5 and 6). It is possible that a subset of motor
neurons (or specific motor terminal branches) do not ex-
press TM-MFas II but are nevertheless ensheathed by GPI-
MFas II-positive glial cells, although in Drosophila, all
motor neurons have been reported to express fasciclin II
during embryogenesis (Schuster et al., 1996a; Van Vactor et
l., 1993). A recent examination of Manduca neuromuscu-
ar junctions in postembryonic animals has also shown that
ll motor terminals remain ensheathed by GPI-MFas II-
xpressing glial cells throughout subsequent life stages
Knittel et al., 2001). Alternatively, this additional glial
laboration may reflect the ensheathment of unstained
ensory afferent fibers en route to the CNS (c.f. Sepp et al.,
Examples of cultured preparations that were treated with ODN-2
prior to bridge formation and DNa outgrowth (compare with Fig. 8).
(B) Preparation in which the DNa failed to defasciculate from the
dorsal nerve. (C, D) Two preparations in which the DNa axons
emerged from the dorsal nerve but then stalled in the vicinity of the
bridge and extended short processes in a variety of inappropriate
directions. (E) Example of the “switchback” phenotype in which
some of the DNa axons projected back towards the CNS. Note that
the organization of the glial cells that normally form the bridge is
substantially less coherent than in the control preparation. DNl,FIG. 9. Effects of ODN GPI-2 on bridge formation and DNa nerve
outgrowth (redrawn from camera lucida images). (A) Cultured
ontrol preparation showing the normal morphology of the glial
ridge (BR) and the trajectory of the DNa branch from off of the
orsal nerve (DN). Asterisk indicates the position of the spiracle;lateral branch of the dorsal nerve. Scale 5 20 mM.












































38 Wright and Copenhaver2000). Simultaneous labeling of sensory neurons and the
glial sheath in developing embryos will be needed to ad-
dress this issue.
Interactions between Axons and Glia Expressing
MFas II
The results of this paper indicate that at least two distinct
types of interaction occurred between TM-MFas II-positive
axons and GPI-MFas II-positive glial cells. The first type,
illustrated by the extension of the DNl branch (Fig. 5),
occurred when axons expressing TM-MFas II navigated to
their targets in advance of glial cells. Axons pioneering the
DNl clearly did not rely on GPI-MFas II-expressing glia as a
substrate for guidance; rather, the DNl formed in a manner
similar to vertebrate peripheral nerves, in which axons
extend into target regions prior to the arrival of glial cells
(Mirsky and Jessen, 1999). The TM-MFas II-expressing
axons subsequently provided one of the substrates followed
by the ensheathing glia during their outgrowth, similar to
the guidance of Schwann cells by axons during vertebrate
development. Based on these results, it is not surprising
that manipulations targeting the GPI-linked isoform had no
effect on the outgrowth of this nerve (Fig. 7, black arrow-
heads; Fig. 8), even when the level of GPI-MFas II expres-
sion in the glial cells surrounding the DNl were substan-
tially reduced (Fig. 8). Although we did not examine
synapse formation in these preparations in any detail, the
overall appearance of the terminal branches of the DNl was
normal, consistent with the arrival of the axons at their
muscle targets prior to ensheathment by the glial processes.
Therefore, in the case of the DNl, the axons conduct their
initial pathfinding independent of glial interactions and
provide support for subsequent glial differentiation.
In contrast, the other class of interaction (illustrated by
the formation of the DNa nerve) suggests that GPI-MFas
II-positive glial cells play an essential role during axonal
guidance in some specific instances. The data shown in Fig.
4 indicated that the glial cells forming the bridge structure
were already present and expressing GPI-MFas II prior to
the arrival of the DNa pioneer growth cones, and that the
morphology of this transient structure prefigured the tra-
jectory subsequently taken by the DNa nerve. Moreover,
removal of GPI-MFas II (with PI-PLC) or inhibition of its
expression (using antisense ODNs) dramatically altered the
formation of this nerve (Figs. 7–9). Both of these manipula-
tions perturbed the trajectory of the DNa axons to some
degree in over 90% of the treated preparations, the most
dramatic of which involved a complete failure of the DNa
to defasciculate from the DNl (Figs. 7C and 8B). More often,
the DNa axons initially extended into the area normally
occupied by the bridge glia but then either stalled or grew in
a variety of inappropriate directions, including back to-
wards the CNS. Treatment with PI-PLC typically resulted
in a complete loss of GPI-MFas II expression and tended to
produce more pronounced errors in DNa formation. While
the relatively low concentration of PI-PLC used in these
Copyright © 2001 by Academic Press. All righttudies did not cause any obvious defects in the DNl branch
which grows in advance of GPI-MFas II-expressing sub-
trates), this enzyme should also cleave other GPI-linked
olecules that might be expressed by the bridge glia. The
ffects of this treatment on DNa branch formation might
herefore reflect the function of additional receptors besides
PI-MFas II. However, our successful application of anti-
ense ODNs designed to inhibit GPI-MFas II expression
lso produced a similar range of defects in DNa formation,
ost often resulting in a stalled phenotype in which the
xons failed to advance normally beyond the malformed
lial bridge. These results indicate that in the case of the
Na branch, axonal pathways are prefigured by a defined
lial structure. This phenomenon is reminiscent of the
Blueprint” hypothesis (as noted by Carr and Taghert,
988), suggesting that some axon pathways may be pre-
pecified by glial or other nonneural structures (Singer et
l., 1979; see Silver, 1993).
What is the role of GPI-MFas II with respect to the
ormation of the DNa branch? Given previous studies
emonstrating that fasciclin II can act as a homophilic
inding protein (reviewed in Goodman et al., 1997), our
nitial assumption was that TM-MFas II-positive axons
ould specifically adhere to GPI-MFas II glial cells either
efore or after their initial outgrowth. This model would
redict that interactions between TM-MFas II receptors on
he growth cones and GPI-MFas II on the glial cells nor-
ally mediate the guidance of the axons across the glial
ridge, and that removal of GPI-MFas II is sufficient to
isrupt this process. An alternative possibility is that GPI-
Fas II simply acts as an adhesion molecule holding the
lial cells in a cohesive group as the bridge structure
ifferentiates, whereupon other molecular components as-
ociated with the bridge provide the actual guidance cues
or the DNa axons. Contrary to our expectations, we
bserved instances where TM-MFas II-positive axons grew
ndependent of GPI-MFas II-positive glial cells (Fig. 5), and
utgrowth of GPI-MFas II-positive glial processes occurred
artially independent of TM-MFas II-expressing axons (Figs.
and 6). Although homophilic adhesion between the iden-
ical extracellular domains of different MFas II isoforms is
ormally possible, whether the transmembrane and GPI-
inked isoforms directly interact in vivo remains to be
etermined.
Functional Differences between MFas II Isoforms
An important issue with respect to the IgSF receptors in
general concerns the potential functions of distinct iso-
forms. While many of these molecules have been shown to
be able to promote cell–cell contact via homophilic inter-
actions (including fasciclin II; Grenningloh et al., 1990),
ample precedent has been established that some IgSF recep-
tors mediate functions beyond simple adhesion. In the case
of transmembrane IgSFs, both NCAM 140 and L1 have been
shown to interact with a variety of intracellular signaling
pathways (e.g., Ignelzi et al., 1994; Beggs et al., 1997;
s of reproduction in any form reserved.
39Fasciclin II Isoforms in the PNSSchmid et al., 1999) which may lead to localized changes
in actin assembly and neuronal motility. Similarly, a
PDZ-binding domain within the cytoplasmic tail of trans-
membrane fasciclin II has been shown to promote interac-
tions with both the Shaker potassium channel and
the membrane-associated guanylate kinase Discs-large
(Thomas et al., 1997; Zito et al., 1997), which may in turn
mediate synaptic growth and plasticity. The role of the
GPI-linked IgSFs is by contrast less well understood. Al-
though a number of GPI-linked cell adhesion receptors have
been shown to interact with nonreceptor tyrosine kinases
(Brown, 1993; Casey, 1995; Olive et al., 1995; Zisch et al.,
1995), no such association has been demonstrated for GPI-
linked isoforms of the NCAM/apCAM/fasciclin II family.
Experiments performed in cell culture have shown that
GPI-linked receptors (such NCAM-120) can act as substrate
molecules that promote neuronal motility in vitro (Doherty
et al., 1990), although other studies performed in vivo have
suggested that GPI-linked isoforms of this family serve a
strictly adhesive function (Martin and Kandel, 1996; Schus-
ter et al., 1996b).
In the case of MFas II, our studies using cultured embryos
support a model in which the two isoforms serve distinct
functions with respect to cellular motility. For example, we
previously showed that an identified set of newly generated
enteric neurons (the EP cells) initially expressed only GPI-
MFas II, and that this isoform maintained strong adhesive
contact between adjacent neurons but did not contribute to
their motility (Wright and Copenhaver, 2000). The EP cells
then switched isoforms to express only TM-MFas II shortly
before commencing a period of rapid migration and out-
growth, events that were inhibited when TM-MFas II ex-
pression was perturbed. Subsequent expression of GPI-
MFas II in the ENS was entirely confined to the enteric glial
cells that, like the glial cells of the PNS, gradually spread
along the pathways formed by the neurons and their pro-
cesses. We also found that the membrane distributions of
the two isoforms were similar in the ENS as reported here:
GPI-MFas II protein appeared to be uniformly distributed
over the entire surface of cells expressing this isoform,
while TM-MFas II was localized to the leading processes of
migrating neurons or their growth cones. The consistent
localization of TM-MFas II to the most motile regions of a
neuron suggests that it may help regulate the cytoskeletal
dynamics associated with migration and outgrowth, as
proposed for other transmembrane isoforms of this receptor
family. In contrast, our data argue that GPI-MFas II may act
primarily as a simple adhesion molecule, maintaining
strong intercellular contacts without directly promoting
intracellular signaling events that might affect cellular
motility. Whether the two isoforms directly interact (one
providing a substrate for cells expressing the other isoform)
or whether either isoform may interact heterophilically
with other receptor types encountered in vivo remain to be
explored.
In summary, we have shown that the two isoforms of
fasciclin II in Manduca are expressed in dynamic and
Copyright © 2001 by Academic Press. All rightdistinct patterns within the developing nervous system.
Notably, we have shown that the well-characterized pat-
tern of fasciclin II in the insect CNS is entirely due to
neuronal expression of the transmembrane isoform. In
contrast, the GPI-linked isoform of MFas II is almost
completely confined to the glial populations that ensheath
the peripheral nerves. Our data support a model whereby
the localized expression of TM-MFas II in the axons and
growth cones of developing neurons may promote their
motility, while GPI-MFas II acts as a simple adhesion
molecule that may also serve as a substrate for axonal
outgrowth in some instances. Finally, we have exploited
the isoform-specific patterns of MFas II expression in the
PNS to show that at some locations, glial cells ensheath
peripheral nerves only after axonal outgrowth, while, in
other regions, glial structures form in advance of the first
growth cones and may provide necessary substrates for
guiding their subsequent trajectories.
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